StonvexLoading…
StonvexStonvexStonvexCore line items from DT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $1.70B | $1.43B | $1.16B | $929.45M |
Operating Income | $179.43M | $128.40M | $92.81M | $81.31M |
Net Income | $483.68M | $154.63M | $107.96M | $52.45M |
EPS (Diluted) | $1.59 | $0.52 | $0.37 | $0.18 |
Total Assets | $4.14B | $3.41B | $2.77B | $2.54B |
Total Liabilities | $1.52B | $1.39B | $1.16B | $1.24B |
Cash & Equivalents | $1.02B | $778.98M | $555.35M | $462.97M |
Free Cash Flow OCF − CapEx | $433.31M | $351.65M | $333.35M | $233.22M |
Shares Outstanding | 299.81M | 296.96M | 290.41M | 286.05M |